Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors-Reference-Cited by-同舟云学术

Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors

Published:2015-10-12 Issue:36 Volume:6 Page:38777-38788
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Hoekstra Attje S.¹,de Graaff Marieke A.²,Briaire-de Bruijn Inge H.²,Ras Cor³,Seifar Reza Maleki³,van Minderhout Ivonne⁴,Cornelisse Cees J.²,Hogendoorn Pancras C.W.²,Breuning Martijn H.⁴,Suijker Johnny²,Korpershoek Esther⁵,Kunst Henricus P.M.⁶,Frizzell Norma⁷,Devilee Peter¹²,Bayley Jean-Pierre¹,Bovée Judith V.M.G.²

Affiliation:

1. Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands

2. Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands

3. Department of Biotechnology, Delft University of Technology, Delft, The Netherlands

4. Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands

5. Department of Pathology, Josephine Nefkens Institute, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands

6. Department of Otorhinolaryngology, Head and Neck Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands

7. Department of Pharmacology, Physiology & Neuroscience, School of Medicine, University of South Carolina, Columbia, SC, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic dysregulation of tricarboxylic acid cycle and oxidative phosphorylation in glioblastoma;Reviews in the Neurosciences;2024-06-07

2. Identification and validation of a pyroptosis-related prognostic model for colorectal cancer based on bulk and single-cell RNA sequencing data;World Journal of Clinical Oncology;2024-02-24

3. Focused Screening Identifies Different Sensitivities of Human TET Oxygenases to the Oncometabolite 2-Hydroxyglutarate;Journal of Medicinal Chemistry;2024-01-31

4. Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemia;Frontiers in Oncology;2024-01-08

5. Mitochondria act as a key regulatory factor in cancer progression: Current concepts on mutations, mitochondrial dynamics, and therapeutic approach;Mutation Research - Reviews in Mutation Research;2024-01